Michael Milsom is currently head of the Division of Experimental Hematology at the German Cancer Research Center in Heidelberg, and Group Leader at the Heidelberg Institute for Stem Cell Technology and Experimental Medicine. One of the main focuses of his research group is the study of the alterations in hematopoietic stem cells that take place during ageing at the level of cell and molecular biology.